Technology News and Research

RSS

Ethicon Endo-Surgery renews research collaboration agreement with UC and Metabolic Diseases Institute

Ethicon Endo-Surgery, Inc. (EES) today announced it has renewed its research collaboration agreement with the University of Cincinnati (UC) and its Metabolic Diseases Institute (MDI). The three-year, $13.5M grant extension, is part of the EES Metabolic Applied Research Strategy (MARS), which also includes research from GI Metabolism Laboratory and Weight Center at the Massachusetts General Hospital (MGH).

22 Jun 2010

Ensemble Discovery announces name change to Ensemble Therapeutics Corporation

Ensemble Discovery today announced that it will begin operating as Ensemble Therapeutics Corporation to reflect the Company's progress and emerging pipeline by applying its macrocycle drug platform to develop novel therapeutics. The new name, Ensemble Therapeutics, conveys the company's leadership and advancement in developing novel macrocycle drug compounds that are small molecules with expanded therapeutic properties of large molecule biological drugs.

22 Jun 2010

Neurologix announces positive results from Phase 2 trial of NLX-P101 for advanced PD

Neurologix, Inc., today announced positive results in a Phase 2 trial of its investigational gene therapy for advanced Parkinson's disease, NLX-P101. Study participants who received NLX-P101 experienced statistically significant and clinically meaningful improvements in off-medication motor scores compared to control subjects who received sham surgery.

22 Jun 2010

World's first invisible-in-the-canal hearing aid launched

Starkey Laboratories, Inc., one of the world's leading hearing technology companies, is excited to introduce the S Series™ iQ OtoLens™, the world's first invisible-in-the-canal (IIC) hearing aid. OtoLens, a custom-molded hearing aid built using Starkey's Comfort Fit process, lives in the second bend of the ear, meaning that it is truly 100 percent invisible.

22 Jun 2010

Medicity receives high ratings in IDC Health Insights' HIE vendor evaluation

A recent study by IDC Health Insights that evaluated HIE vendors based on fit to market needs and ability to provide clients with a positive ownership experience placed Medicity as a leading vendor in the HIE technologies market.

22 Jun 2010

Aurora Dedicated Breast MRI System installed at Ruijin Hospital, China

Aurora Imaging Technology, Inc. today announced the installation of the Aurora® Dedicated Breast MRI System in China at the world-renowned Ruijin Hospital located in Shanghai, the teaching hospital for China's top-tiered Jiao Tong University Medical School. The installation marks the first Aurora System in China.

22 Jun 2010

Tobii Technology announces launch of cost-effective eye tracking system

Tobii Technology, the global market leader in eye tracking, today announces the launch of Tobii Glasses™ a revolutionary, cost-effective eye tracking system. Tobii Glasses will help researchers in commercial, scientific, and government organisations to gain greater levels of insight into the preferences, reactions and personal experiences of people in a natural environment.

22 Jun 2010

First Edition: June 22, 2010

In this Kaiser Health News consumer column, Michelle Andrews writes: "High-deductible health plans and the health savings accounts (HSAs) that link to them are becoming a familiar fixture on the insurance landscape, even though they get mixed reviews from many consumers and health-policy experts" (Kaiser Health News).

22 Jun 2010

Ohio Third Frontier helps drive innovation and opportunity in biomedical industry

Ohio Third Frontier, and the strategic investments made by the program to bolster Ohio's biomedical imaging industry, serve as a national model for success and are the primary reason behind Ohio's position as a national hub for innovation and opportunity in the thriving biomedical industry.

22 Jun 2010

New report measures growing adoption of centralized ECG services

ERT, a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries, announced today the availability of a new report, conducted by the Tufts Center for the Study of Drug Development, mapping the growing adoption of centralized ECG (electrocardiogram) services. The industry-wide report measures the current and anticipated adoption levels of centralized ECGs in clinical trials.

22 Jun 2010

Methodist surgeons study transvaginal removal of donor kidney

Surgeons at The Methodist Hospital in Houston are studying a new way to make kidney donation safer, less invasive and almost scar free for women by using a new technique that removes kidneys transvaginally.

22 Jun 2010

Complimentary analyst briefing on the potential of European remote patient monitoring market

Across Europe, governments have realized the need to introduce remote monitoring into the mainstream of healthcare services. Currently, the market experiences heavy investment regarding the development of various patient monitoring systems using information and communication technology and enabling the remote monitoring of a patient.

22 Jun 2010

TraceLink, Catalent announce partnership to improve production visibility for customers

TraceLink, Inc., the provider of the World's 1st Industry-Wide Supply Collaboration Network, and Catalent Pharma Solutions, Inc., a leading provider of innovative drug development and delivery solutions for pharmaceutical, biotechnology and consumer healthcare companies, today announced a partnership that will improve production visibility for Catalent customers across their entire manufacturing and packaging product lifecycle.

22 Jun 2010

Regulus Therapeutics, sanofi-aventis partner to develop and commercialize microRNA therapeutics

Regulus Therapeutics Inc. and sanofi-aventis announced today that they have entered into a global, strategic alliance to discover, develop, and commercialize microRNA therapeutics. The alliance represents the largest microRNA partnership formed to date, valued at potentially over $750 million, and includes a $25 million upfront fee, a $10 million future equity investment subject to mutual agreement on company valuation, and annual research support for three years with the option to extend two additional years.

22 Jun 2010

Protea Biosciences, Mayoly-Spindler commence Phase I/IIA human clinical trial for new recombinant Lipase

Protea Biosciences, Inc., a leading developer of new technology for pharmaceutical research, announced today that the company, in partnership with Mayoly-Spindler, a European pharmaceutical company, has commenced a Phase I/IIA human clinical trial for a new recombinant Lipase.

22 Jun 2010

Investment report on ULURU

MicroStockProfit.com announces an investment report featuring ULURU Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

22 Jun 2010

New legal, ethical framework needs to be placed around banking of human biological material: Review

A lawyer and researcher at the Johns Hopkins Berman Institute of Bioethics says a new legal and ethical framework needs to be placed around the donation and banking of human biological material, one that would more clearly define the terms of the material's use - and address donor expectations before research begins.

22 Jun 2010

SynCon DNA vaccine shows advantages in magnitude and breadth of immune responses in non-human primates

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.

22 Jun 2010

Michigan State University researchers analyze histiocytic sarcomas

Michigan State University veterinarians are taking part in a two-year, $5.3 million project to analyze five cancers in dogs, research that could offer new insight into canine cancer genes and their potential impact on the human form of the disease.

22 Jun 2010

Gardner Family Health Network to deploy NextGen Ambulatory EHR, Practice Management, QSI Dental System

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, today announced an agreement with Gardner Family Health Network to deploy NextGen® Ambulatory EHR and NextGen® Practice Management, as well as the QSI Dental System. Gardner is the 42nd health center in California to partner with NextGen Healthcare.

22 Jun 2010

Technology News and Research

Ethicon Endo-Surgery renews research collaboration agreement with UC and Metabolic Diseases Institute

Ensemble Discovery announces name change to Ensemble Therapeutics Corporation

Neurologix announces positive results from Phase 2 trial of NLX-P101 for advanced PD

World's first invisible-in-the-canal hearing aid launched

Medicity receives high ratings in IDC Health Insights' HIE vendor evaluation

Aurora Dedicated Breast MRI System installed at Ruijin Hospital, China

Tobii Technology announces launch of cost-effective eye tracking system

First Edition: June 22, 2010

Ohio Third Frontier helps drive innovation and opportunity in biomedical industry

New report measures growing adoption of centralized ECG services

Methodist surgeons study transvaginal removal of donor kidney

Complimentary analyst briefing on the potential of European remote patient monitoring market

TraceLink, Catalent announce partnership to improve production visibility for customers

Regulus Therapeutics, sanofi-aventis partner to develop and commercialize microRNA therapeutics

Protea Biosciences, Mayoly-Spindler commence Phase I/IIA human clinical trial for new recombinant Lipase

Investment report on ULURU

New legal, ethical framework needs to be placed around banking of human biological material: Review

SynCon DNA vaccine shows advantages in magnitude and breadth of immune responses in non-human primates

Michigan State University researchers analyze histiocytic sarcomas

Gardner Family Health Network to deploy NextGen Ambulatory EHR, Practice Management, QSI Dental System

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News